Unknown

Dataset Information

0

Fibroblast growth factor 23, endothelium biomarkers and acute kidney injury in critically-ill patients.


ABSTRACT: BACKGROUND:Fibroblast growth factor 23 (FGF23) and endothelium-related biomarkers have been related to AKI in critically-ill patients. Also, FGF23 is associated with endothelial dysfunction. In this study, we investigated if elevated FGF23 association with severe AKI is mediated by several endothelial/glycocalyx-related biomarkers. METHODS:Prospective cohort study with critically-ill patients. Blood samples were collected within the first 24 h after ICU admission. Severe AKI (defined according to KDIGO stage 2/3) was the analyzed outcome. RESULTS:265 patients were enrolled and 82 (30.9%) developed severe AKI-defined according to KDIGO stage 2/3. Blood samples to biomarkers measurement were collected within the first 24 h after ICU admission. After adjustment for several variables, FGF23, vascular cell adhesion protein 1 (VCAM-1), angiopoietin 2 (AGPT2), syndecan-1 and intercellular adhesion molecule-1 (ICAM-1) were associated with severe AKI. The individual indirect effects of VCAM-1, AGPT2 and syndecan-1 explained 23%, 31%, and 32% of the total observed effect of FGF23 on severe AKI, respectively. ICAM-1 showed no statistically significant mediation. When all three endothelium-related biomarkers were included in a directed acyclic graph (DAG), the Bayesian network learning suggested the following causal association pathway FGF-23???syndecan-1???VCAM-1???AGPT2???severe AKI. CONCLUSIONS:The association between FGF23 and AKI are mediated by endothelium-related biomarkers, mainly VCAM-1, AGPT2 and syndecan-1. Moreover, the statistical models show that syndecan-1, a biomarker of endothelial glycocalyx dysfunction, seems to be the initial mediator between FGF23 and severe AKI.

SUBMITTER: de Oliveira Neves FM 

PROVIDER: S-EPMC6458699 | biostudies-literature | 2019 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications


<h4>Background</h4>Fibroblast growth factor 23 (FGF23) and endothelium-related biomarkers have been related to AKI in critically-ill patients. Also, FGF23 is associated with endothelial dysfunction. In this study, we investigated if elevated FGF23 association with severe AKI is mediated by several endothelial/glycocalyx-related biomarkers.<h4>Methods</h4>Prospective cohort study with critically-ill patients. Blood samples were collected within the first 24 h after ICU admission. Severe AKI (defi  ...[more]

Similar Datasets

| S-EPMC5969465 | biostudies-literature
| S-EPMC4769222 | biostudies-literature
| S-EPMC6773527 | biostudies-literature
| S-EPMC10744752 | biostudies-literature
| S-EPMC5823799 | biostudies-literature
| S-EPMC9977639 | biostudies-literature
| S-EPMC9625110 | biostudies-literature
| S-EPMC8999255 | biostudies-literature
| S-EPMC8661170 | biostudies-literature
| S-EPMC6811773 | biostudies-literature